Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

31551
1
NI Holdings, Inc. Ni Holdings Reports Revenue Growth, Net Loss in Q3 2024 Amid Strategic Changes

Via official filing (AI summary) | over 1 year ago | 0 comments

31552
1
Diamondback Energy, Inc. Diamondback Energy Reports Revenue Growth, Strategic Acquisitions, and Increased Debt in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31553
1
Co-Diagnostics, Inc. Co-Diagnostics Reports Significant Financial Decline, Net Loss Widens in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31554
1
Bunker Hill Mining Corp. Bunker Hill Mining Reports Significant Financial Challenges, Net Loss of $8.1 Million in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31555
1
Claros Mortgage Trust, Inc. Claros Mortgage Trust Reports Decline in Revenues and Net Income Amid Challenging Market Conditions

Via official filing (AI summary) | over 1 year ago | 0 comments

31556
1
DT Cloud Acquisition Corp DT Cloud Acquisition Corporation Reports Significant Financial Changes, Net Income Recovery in Latest 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments

31557
1
RELMADA THERAPEUTICS, INC. Relmada Therapeutics Reports Significant Financial Decline, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31558
1
SUPERIOR INDUSTRIES INTERNATIONAL INC Superior Industries Reports Mixed Q3 Results Amid Challenging Market Conditions

Via official filing (AI summary) | over 1 year ago | 0 comments

31559
1
Intellia Therapeutics, Inc. Intellia Therapeutics Reports Financial Challenges, Decrease in Cash Reserves, and Increased Research and Development Expenses

Via official filing (AI summary) | over 1 year ago | 0 comments

31560
1
CYTOKINETICS INC Cytokinetics Reports Significant Revenue Growth, Widened Losses in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

31561
1
GERON CORP Geron Corporation Reports Significant Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31562
1
Phathom Pharmaceuticals, Inc. Phathom Pharmaceuticals Reports Revenue Growth, Net Loss in Q3 2024, Amid Strategic Progress and Financial Challenges

Via official filing (AI summary) | over 1 year ago | 0 comments

31563
1
SpartanNash Co SpartanNash Reports Mixed Financial Results for 12 and 40 Weeks Ended October 5, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31564
1
authID Inc. authID Inc. Reports Increased Cash and Assets, Revenue Growth, and Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

31565
1
Redfin Corp Redfin Reports Mixed Q3 2024 Results with 3% Revenue Growth and Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments

31566
1
ACM Research, Inc. ACM Research Reports 21% Revenue Growth to $203.98M in Q3 2024, 44.2% Growth for Nine Months

Via official filing (AI summary) | over 1 year ago | 0 comments

31567
1
CytomX Therapeutics, Inc. CytomX Therapeutics Reports 27% Revenue Growth, Net Income Improvement in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31568
1
Moderna, Inc. Moderna Reports Mixed Q3 Results, Net Income Turnaround, and FDA Approval for RSV Vaccine

Via official filing (AI summary) | over 1 year ago | 0 comments

31569
1
EyePoint Pharmaceuticals, Inc. Eyepoint Pharmaceuticals Reports 31% Revenue Decline, Widened Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31570
1
Viper Energy, Inc. Viper Energy Reports Significant Financial Developments in 10-Q Filing for Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31571
1
WOLVERINE WORLD WIDE INC /DE/ Wolverine World Wide Reports 16.6% Revenue Decline in Q3 2024, Net Earnings Increase 170%

Via official filing (AI summary) | over 1 year ago | 0 comments

31572
1
AIR LEASE CORP Air Lease Corporation Reports Mixed Q3 Results with 4.7% Revenue Growth and Decreased Net Income

Via official filing (AI summary) | over 1 year ago | 0 comments

31573
1
TEGNA INC TEGNA Reports 13% Revenue Growth, 71% Operating Income Increase in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31574
1
INTERNATIONAL TOWER HILL MINES LTD International Tower Hill Mines Ltd. Reports Slight Improvement in Net Loss, Focuses on Livengood Gold Project

Via official filing (AI summary) | over 1 year ago | 0 comments

31575
1
Nutex Health, Inc. Nutex Health Reports 25.6% Revenue Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments